CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $400,176 | -30.1% | 95,280 | 0.0% | 0.31% | -34.1% |
| Q4 2022 | $572,633 | +3.2% | 95,280 | 0.0% | 0.47% | -5.6% |
| Q3 2022 | $555,000 | -5.0% | 95,280 | -2.6% | 0.50% | +0.2% |
| Q2 2022 | $584,000 | +27.8% | 97,780 | 0.0% | 0.50% | +43.8% |
| Q1 2022 | $457,000 | +88.8% | 97,780 | 0.0% | 0.34% | +93.8% |
| Q4 2021 | $242,000 | – | 97,780 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|